Erratum: Disruption of early tumor necrosis factor alpha signaling prevents classical activation of dendritic cells in lung-associated lymph nodes and development of protective immunity against cryptococcal infection (mBio, (2016) 7, 4, e00510-16, 10.1128/mBio.00510-16);Disruption of early tumor necrosis factor alpha signaling prevents classical activation of dendritic cells in lung-associated lymph nodes and development of protective immunity against cryptococcal infection

mBio

Volumn 7, Issue 4, 2016, Pages

  Xu, Jintao ^a,c   Eastman, Alison J ^b   Flaczyk, Adam ^a,c   Neal, Lori M ^a,c   Zhao, Guolei ^a,c   Carolan, Jacob ^c   Malachowski, Antoni N ^a,c   Stolberg, Valerie R ^a,c   Yosri, Mohammed ^a,c   Chensue, Stephen W ^a,c   Curtis, Jeffrey L ^a,b,c   Osterholzer, John J ^a,b,c   Olszewski, Michal A ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL POLARITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LUNG ASSOCIATED LYMPH NODE; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BACTERIAL LOAD; DISEASE MODEL; IMMUNOLOGY; LUNG; LUNG DISEASES; MICROBIOLOGY;

ANIMALS; BACTERIAL LOAD; CD4-POSITIVE T-LYMPHOCYTES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; LUNG; LUNG DISEASES; LYMPH NODES; MICE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84986568013     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01039-18     Document Type: Erratum

References (42)

1. Bradley JR. 2008. TNFα mediated inflammatory disease. J Pathol 214: 149-160. http://dx.doi.org/10.1002/path.2287.
2. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. 2008. Fungal infections complicating tumor necrosis factor α blockade therapy. Mayo Clin Proc 83:181-194. http://dx.doi.org/10.1016/S0025-6196(11)60839-2.
3. Ellerin T, Rubin RH, Weinblatt ME. 2003. Infections and anti-tumor necrosis factor α therapy. Arthritis Rheum 48:3013-3022. http://dx.doi.org/10.1002/art.11301.
4. Rohatgi S, Pirofski LA. 2015. Host immunity to Cryptococcus neoformans. Future Microbiol 10:565-581. http://dx.doi.org/10.2217/fmb.14.132.
5. Durden FM, Elewski B. 1997. Fungal infections in HIV-infected patients. Semin Cutan Med Surg 16:200-212. http://dx.doi.org/10.1016/S1085-5629(97)80043-0.
6. Chuck SL, Sande MA. 1989. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321:794-799. http://dx.doi.org/10.1056/NEJM198909213211205.
7. Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE. 2001. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33:690-699. http://dx.doi.org/10.1086/322597.
8. Olszewski MA, Zhang Y, Huffnagle GB. 2010. Mechanisms of cryptococcal virulence and persistence. Future Microbiol 5:1269-1288. http://dx.doi.org/10.2217/fmb.10.93.
9. Wager CML, Wormley FL, Jr. 2015. Is development of a vaccine against Cryptococcus neoformans feasible? PLoS Pathog 11:e1004843. http://dx.doi.org/10.1371/journal.ppat.1004843.
10. He X, Lyons DM, Toffaletti DL, Wang F, Qiu Y, Davis MJ, Meister DL, Dayrit JK, Lee A, Osterholzer JJ, Perfect JR, Olszewski MA. 2012. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination. Am J Pathol 181: 1356-1366. http://dx.doi.org/10.1016/j.ajpath.2012.06.012.
11. Osterholzer JJ, Surana R, Milam JE, Montano GT, Chen GH, Sonstein J, Curtis JL, Huffnagle GB, Toews GB, Olszewski MA. 2009. Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung. Am J Pathol 174: 932-943. http://dx.doi.org/10.2353/ajpath.2009.080673.
12. Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA. 2009. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol 175:2489-2500. http://dx.doi.org/10.2353/ajpath.2009.090530.
13. Kawakami K, Hossain Qureshi M, Zhang T, Koguchi Y, Xie Q, Kurimoto M, Saito A. 1999. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-γ-inducing cytokines. Cell Immunol 197: 55-61. http://dx.doi.org/10.1006/cimm.1999.1557.
14. Müller U, Stenzel W, Köhler G, Werner C, Polte T, Hansen G, Schütze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol 179:5367-5377. http://dx.doi.org/10.4049/jimmunol.179.8.5367.
15. Blackstock R, Murphy JW. 2004. Role of interleukin-4 in resistance to Cryptococcus neoformans infection.Am J Respir Cell Mol Biol 30:109-117. http://dx.doi.org/10.1165/rcmb.2003-0156OC.
16. Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, Kunkel SL, Strieter RM. 1996. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 157:4529-4536. PubMed.
17. Herring AC, Lee J, McDonald RA, Toews GB, Huffnagle GB. 2002. Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection. Infect Immun 70:2959-2964. http://dx.doi.org/10.1128/IAI.70.6.2959-2964.2002.
18. Herring AC, Falkowski NR, Chen G.-H, McDonald RA, Toews GB, Huffnagle GB. 2005. Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells. Infect Immun 73:39-49. http://dx.doi.org/10.1128/IAI.73.1.39-49.2005.
19. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-252. http://dx.doi.org/10.1038/32588.
20. Bozza S, Gaziano R, Spreca A, Bacci A, Montagnoli C, di Francesco P, Romani L. 2002. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 168:1362-1371. http://dx.doi.org/10.4049/jimmunol.168.3.1362.
21. Cook PC, Jones LH, Jenkins SJ, Wynn TA, Allen JE, MacDonald AS. 2012. Alternatively activated dendritic cells regulate CD4+ T-cell polarization in vitro and in vivo. Proc Natl Acad Sci U S A 109:9977-9982. http://dx.doi.org/10.1073/pnas.1121231109.
22. Weitnauer M, Schmidt L, Ng Kuet Leong N, Muenchau S, Lasitschka F, Eckstein V, Hübner S, Tuckermann J, Dalpke AH. 2014. Bronchial epithelial cells induce alternatively activated dendritic cells dependent on glucocorticoid receptor signaling. J Immunol 193:1475-1484. http://dx.doi.org/10.4049/jimmunol.1400446.
23. Eastman AJ, Osterholzer JJ, Olszewski MA. 2015. Role of dendritic cellpathogen interactions in the immune response to pulmonary cryptococcal infection. Future Microbiol 10:1837-1857. http://dx.doi.org/10.2217/fmb.15.92.
24. Fairweather D, Cihakova D. 2009. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 33:222-230. http://dx.doi.org/10.1016/j.jaut.2009.09.012.
25. Lindell DM, Moore TA, McDonald RA, Toews GB, Huffnagle GB. 2006. Distinct compartmentalization of CD4+ T-cell effector function versus proliferative capacity during pulmonary cryptococcosis. Am J Pathol 168: 847-855. http://dx.doi.org/10.2353/ajpath.2006.050522.
26. Wiesner DL, Specht CA, Lee CK, Smith KD, Mukaremera L, Lee ST, Lee CG, Elias JA, Nielsen JN, Boulware DR, Bohjanen PR, Jenkins MK, Levitz SM, Nielsen K. 2015. Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection. PLoS Pathog 11:e1004701. http://dx.doi.org/10.1371/journal.ppat.1004701.
27. Wozniak KL, Vyas JM, Levitz SM. 2006. In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis. Infect Immun 74: 3817-3824. http://dx.doi.org/10.1128/IAI.00317-06.
28. Ramirez-Ortiz ZG, Means TK. 2012. The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans). Virulence 3:635-646. http://dx.doi.org/10.4161/viru.22295.
29. D’Ostiani CF, Del Sero G, Bacci A, Montagnoli C, Spreca A, Mencacci A, Ricciardi-Castagnoli P, Romani L. 2000. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191:1661-1674. http://dx.doi.org/10.1084/jem.191.10.1661.
30. Guilliams M, Lambrecht BN, Hammad H. 2013. Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections. Mucosal Immunol 6:464-473. http://dx.doi.org/10.1038/mi.2013.14.
31. Del Rio ML, Bernhardt G, Rodriguez-Barbosa JI, Förster R. 2010. Development and functional specialization of CD103+ dendritic cells. Immunol Rev 234:268-281. http://dx.doi.org/10.1111/j.0105-2896.2009.00874.x.
32. Friedl P, Den Boer AT, Gunzer M. 2005. Tuning immune responses: diversity and adaptation of the immunological synapse. Nat Rev Immunol 5:532-545. http://dx.doi.org/10.1038/nri1647.
33. Hommel M. 2004. On the dynamics of T-cell activation in lymph nodes. Immunol Cell Biol 82:62-66. http://dx.doi.org/10.1111/j.1440-1711.2004.01209.x.
34. Murdock BJ, Huffnagle GB, Olszewski MA, Osterholzer JJ. 2014. Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production. Infect Immun 82:937-948. http://dx.doi.org/10.1128/IAI.01477-13.
35. Bauman SK, Nichols KL, Murphy JW. 2000. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses. J Immunol 165:158-167. http://dx.doi.org/10.4049/jimmunol.165.1.158.
36. Bauman SK, Huffnagle GB, Murphy JW. 2003. Effects of tumor necrosis factor alpha on dendritic cell accumulation in lymph nodes draining the immunization site and the impact on the anticryptococcal cell-mediated immune response. Infect Immun 71:68-74. http://dx.doi.org/10.1128/IAI.71.1.68-74.2003.
37. Traynor TR, Herring AC, Dorf ME, Kuziel WA, Toews GB, Huffnagle GB. 2002. Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity. J Immunol 168:4659-4666. http://dx.doi.org/10.4049/jimmunol.168.9.4659.
38. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, Hilkens CM, Tam J, Poidinger M, Stanley ER. 2013. IRF4 transcription factor-dependent CD11b+dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38:970-983. http://dx.doi.org/10.1016/j.immuni.2013.04.011.
39. Elgueta R, Benson MJ, De Vries VC, Wasiuk A, Guo Y, Noelle RJ. 2009. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229:152-172. http://dx.doi.org/10.1111/j.1600-065X.2009.00782.x.
40. Chen G.-H, Osterholzer JJ, Choe MY, McDonald RA, Olszewski MA, Huffnagle GB, Toews GB. 2010. Dual roles of CD40 on microbial containment and the development of immunopathology in response to persistent fungal infection in the lung. Am J Pathol 177:2459-2471. http://dx.doi.org/10.2353/ajpath.2010.100141.
41. Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB. 2000. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 165:6429-6436. http://dx.doi.org/10.4049/jimmunol.165.11.6429.
42. Qiu Y, Dayrit JK, Davis MJ, Carolan JF, Osterholzer JJ, Curtis JL, Olszewski MA. 2013. Scavenger receptor A modulates the immune response to pulmonary Cryptococcus neoformans infection. J Immunol 191: 238-248. http://dx.doi.org/10.4049/jimmunol.1203435.